-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HEWafCykyVQlwSLhSg1v3vBanMYhXGHLNaw47ZcW0oOSTbKbJyPf7NPzCp9hIfBF
 ZlUDit/ItkRoA2useSwowA==

<SEC-DOCUMENT>0000950123-11-006532.txt : 20110128
<SEC-HEADER>0000950123-11-006532.hdr.sgml : 20110128
<ACCEPTANCE-DATETIME>20110128133303
ACCESSION NUMBER:		0000950123-11-006532
CONFORMED SUBMISSION TYPE:	FWP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20110128
DATE AS OF CHANGE:		20110128

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adecoagro S.A.
		CENTRAL INDEX KEY:			0001499505
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - LIVESTOCK & ANIMAL SPECIALTIES [0200]
		STATE OF INCORPORATION:			N4

	FILING VALUES:
		FORM TYPE:		FWP
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-171683
		FILM NUMBER:		11554936

	BUSINESS ADDRESS:	
		STREET 1:		13-15 Avenue de la Liberte
		CITY:			N/A
		STATE:			N4
		ZIP:			L-1931

	MAIL ADDRESS:	
		STREET 1:		13-15 Avenue de la Liberte
		CITY:			N/A
		STATE:			N4
		ZIP:			L-1931

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adecoagro S.A.
		CENTRAL INDEX KEY:			0001499505
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - LIVESTOCK & ANIMAL SPECIALTIES [0200]
		STATE OF INCORPORATION:			N4

	FILING VALUES:
		FORM TYPE:		FWP

	BUSINESS ADDRESS:	
		STREET 1:		13-15 Avenue de la Liberte
		CITY:			N/A
		STATE:			N4
		ZIP:			L-1931

	MAIL ADDRESS:	
		STREET 1:		13-15 Avenue de la Liberte
		CITY:			N/A
		STATE:			N4
		ZIP:			L-1931
</SEC-HEADER>
<DOCUMENT>
<TYPE>FWP
<SEQUENCE>1
<FILENAME>y89313afwp.htm
<DESCRIPTION>FWP
<TEXT>
<HTML>
<HEAD>
<TITLE>fwp</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Issuer Free Writing Prospectus Filed Pursuant to Rule&nbsp;433<BR>
Relating to Preliminary Prospectus dated January&nbsp;28, 2011<BR>
Registration Statement No.&nbsp;333-171683
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ISSUER
FREE WRITING PROSPECTUS DATED JANUARY 28, 2011<BR>
ADECOAGRO S.A.<BR>


<DIV style="margin-top: 2pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent">
    <IMG src="y89313ay8780411a.gif" alt="(ADECOAGRO LOGO)">
</DIV>

<DIV style="margin-top: 9pt; font-size: 1pt">&nbsp;</DIV>




28,571,428 Common Shares</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This free writing prospectus relates only to the securities described below and is being filed
to advise you of the availability of, and should be read together with, the revised preliminary
prospectus dated January&nbsp;28, 2011 (the &#147;Preliminary Prospectus&#148;) relating to this offering,
included in Amendment No.&nbsp;3 to the Registration Statement on Form F-1 (File No.&nbsp;333-171683) (the
&#147;Registration Statement&#148;). A hyperlink to the current version of the Registration Statement is
provided below. This free writing prospectus is only a summary of the changes included in the
revised Preliminary Prospectus and you should read the entire Preliminary Prospectus carefully,
including the section entitled &#147;Risk Factors&#148; and the financial statements and related notes,
before deciding to invest in the securities described below.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following information summarizes, supplements and/or updates the information contained in
the Preliminary Prospectus.
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>***************************</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Terms of the Initial Public Offering</B>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Issuer:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Adecoagro S.A.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Security:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Common shares, par value $1.50 per share (the &#147;Common Shares&#148;)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Number of Shares Issued by the Company in this Offering:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">28,405,925 Common Shares</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Number of Shares Sold by the Selling Shareholders in this Offering:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom"><!-- Insert HTML here -->165,503 Common Shares</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Price
to Public:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$11.00 per Common Share</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Al Gharrafa Transaction:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We are selling 7,440,476 common
shares to Al Gharrafa (at a price of $10.56 per share, reflecting the price paid by the underwriters in this offering).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Over-allotment Option:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The underwriters also may purchase
an additional 4,285,714 Common Shares at the public offering price within 30&nbsp;days of the date hereof in order to cover over-allotments, if any.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Use
of Proceeds:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We expect to receive $295 million of net proceeds from the sale of shares by us in this offering, after
deducting the underwriters' discounts and commissions and estimated expenses incurred in connection with
this offering, assuming that the over-allotment option is not exercised. If the underwriters fully exercise their over-allotment option, we expect to receive $340 million of net proceeds.
</TD>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">In addition, we expect to receive $79 million of net proceeds from the sale of shares by us to Al Gharrafa
in the Al Gharrafa Transaction, based on a price per share equal to $10.56 per share to be paid by
Al Gharrafa, reflecting the price paid by the underwriters in this
offering.</td>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We intend to use (i) approximately
$230 million of the net proceeds from this offering and the
Al Gharrafa Transaction to finance part of the construction costs of Ivinhema, our new sugar and ethanol mill in Brazil,
(ii) approximately $143&nbsp;million for potential investments in the acquisition of farmland and capital
expenditures required in the expansion of our farming business, and (iii) the remainder, if any,
for working capital and general corporate purposes.</td>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Share
Capital Before and after the Offering and the Al Gharrafa Transaction:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Our issued and outstanding share
capital consists of 79,999,985 common shares as of the date of this
prospectus. Immediately after the offering and the Al Gharrafa
Transaction, we will have 115,846,386 common shares issued and outstanding, assuming no exercise of the underwriters&#146; over-allotment option. If the underwriters exercise their over-allotment option in full, we will have 120,132,100 common shares issued and outstanding.</TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Trade
Date:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">January&nbsp;28, 2011</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Settlement
Date:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">February&nbsp;2, 2011</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Underwriters</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Credit Suisse Securities (USA) LLC<BR>
Morgan Stanley &amp; Co. Incorporated<BR>
Itau BBA USA Securities Inc.<BR>
Deutsche Bank Securities Inc.<BR>
Banco do Brasil Securities LLC<BR>
HSBC Securities (USA) Inc.<BR>
Rabo Securities USA, Inc.<BR>
Santander Investment Securities Inc.</TD>
</TR>

<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>


<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>CUSIP/ISIN:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">L00849106/LU0584671464</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 18pt">Existing
Adecoagro S.A. shareholders, Stichting Pensioenfonds Zorg en Welzijn
and Ospraie Special Opportunities Master Holdings Ltd.,
have agreed to purchase 4.5&nbsp;million and
1.45&nbsp;million shares
of common stock, respectively, in the offering at the public offering price. Following these purchases, Stichting Pensioenfonds
Zorg en Welzijn and Ospraie Special Opportunities Master Holdings Ltd. will own 13.21% and 9.34%, respectively, of our common
stock assuming that the over-allotment option is not exercised. The underwriters will not receive any underwriting
discount or commissions in connection with the sale of these
shares.</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">*****************************
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To review the Preliminary Prospectus included in the Registration Statement, click the
following link on the SEC website at <U>www.sec.gov</U> as follows (or if such address has
changed, by reviewing the Company&#146;s filings for the relevant
date on the SEC web site):
<U>http://www.sec.gov/Archives/edgar/data/1499505/000095012311006362/y87804a3fv1za.htm</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>OUR CENTRAL INDEX KEY, OR CIK, ON THE SEC WEB SITE IS 0001499505.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>THE ISSUER HAS FILED A REGISTRATION STATEMENT (INCLUDING A PROSPECTUS) WITH THE SEC FOR THE
OFFERING TO WHICH THIS COMMUNICATION RELATES. BEFORE YOU INVEST, YOU SHOULD READ THE PROSPECTUS IN
THAT REGISTRATION STATEMENT AND OTHER DOCUMENTS THE ISSUER HAS FILED WITH THE SEC FOR MORE COMPLETE
INFORMATION ABOUT THE ISSUER AND THIS OFFERING. YOU MAY OBTAIN THESE DOCUMENTS FOR FREE BY VISITING
EDGAR ON THE SEC WEB SITE AT WWW.SEC.GOV. ALTERNATIVELY, ANY UNDERWRITER OR ANY DEALER
PARTICIPATING IN THE OFFERING WILL ARRANGE TO SEND YOU THE PROSPECTUS IF YOU REQUEST IT BY CALLING
CREDIT SUISSE SECURITIES (USA)&nbsp;LLC TOLL FREE AT 1-800-221-1037, MORGAN STANLEY &#038; CO. INCORPORATED TOLL FREE
AT 1-800-584-6837, ITAU BBA USA SECURITIES INC. TOLL FREE AT
1-888-770-4828 OR DEUTSCHE BANK SECURITIES INC.
TOLL FREE AT 1-800-503-4611.</b>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW OR ELSEWHERE WITHIN THE EMAIL ARE NOT
APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE
AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL
SYSTEM.</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>y89313ay8780411a.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 y89313ay8780411a.gif
M1TE&.#EA7P!C`-4@`("<D4!K64!`0,#`P!!%,!`0$/#P\*"@H-#0T&!@8#!>
M3"`@("!2/C`P,.#@X*"UK=#;UE!04'!P</#S\I"IGV"$=9"0D.#GY%!W9W"0
M@["PL+#"N\#.R("`@``Y(@```/___P``````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````"'Y!`$``"``+`````!?`&,```;_
M0)!P2"P:C\BAPQ(I?)X"0:)#K5H<R:QVR^T6EPUH9X#UFL_H\R#R*20TAK1\
M3B<.PHM#G&@86#I1@8*#@AUUAUL(`A\"`T4:$F%/#5)5EI>7&HB;1082'PN:
M0P@)3@L)!PB<JW0("Q^&0P.+!1*JK+AR!Q\-MR"SC`=&"`<=$83(R5$6N6<)
M'PE[!FP+CD,&!TU/"P(2F-_@5&7-6@;/S$(:!07H0@//O&/D\YUAPD*?`N/`
M"U?T_T38W#.P*!8(!XL:W+NFP5@424\B2IQ(\4D"@$.>#6Q00!0("^L6'K0@
MJ4"E<"B_C:-GX</&`K<(0MOSBQ:JE1@W(8`FQ`#'_UL(."Y4!$I/SEP&%C38
MTP3HNIB?\A1!8"%!E(I8LTJ,,._3K0XNA2`HL%1L&(,@2#EA-"6E6TPT6>V,
M->"#A)X+%NP9N\`7/PG6CAX2L&"(TB$_TY&51DVDX#IU[X']^D'4V+*_UK4#
M@4V"`(A:0U,L$!<182$.:HFUBWJQD%T-]K$!%>&M[4LX(8<%46K/:2$<]^RZ
MB'I1O]R/O20HS+E`K%W6P%K3P/-UR.1U5'_\4(8;:M8'36;\$('FDL^BTU<D
M?HAZ=^+4K?460GC/,X-$&=W>3\7QG.6KB1(!<P[`\MH'UNQB4%1&86?&`G=M
MU],'Z$A`FA#>A<>5$/<YB/]&@:((L.$N[QUXBP`7\K9;6@F`IMZ+`K3'G1`&
M\L;<3@(VL-H]+0U$C3?\[7=(!P6L9DT#Q+4T(3JE]%3`ACZQXV$75KGSP1X4
M"G%,.C."H%U+930U91<B"@'6=]9T8V:1:2%(WX9UH>/`;"_6F24=`L32@8Z_
M?'!+C57VB263S!F@V0"()JKHHHPVNBAR9N1I9HQ]#K%;%&9^8"1P$1()Z9CX
MW'-`A(H,(<`M$HA*J2(GWB-!A*#&*BL]$WC@@1"V`@!"`!X$`$(&MG+`0:[#
MV@J"K1X4VRNOQLXZQ`48>*``"!?82L&NO6*;+`7$(GMLL,@&P.RM=2B`[+GH
MIJO_[KK)_FHK!-]F`(*Y'EP`0*[WVEHMN+:*ZVT=X[(KL,`8P%NLKP_8NL&^
M!(`0;;+`2JMLPOW22ZZS1%!`P+L@,.!!P]QZ@`$(&WLP`;,8A)PLLOE*>\@%
MPL8L\\PTUSPS`!8_`$*^NGKLP0,;V*I`K=96('3++?M:A[(#-\TN`1N`0#$#
M$X3<L-$>`$"Q!Q#X7,&X2!]"M--DG\L``!/L;"L!$%Q0,@#[ULLL`Q`@&S2R
M$7L0]2$V]^WWS$-L0"_;$]`[+;,5Q`U`WEMCX'.]B,#\]^0U4U#!XW07CBP$
M6T.[><D88)TUL@QL4G?9J"-+`-I=(_L`!"5GH&P%+6_M_T'>\F[R>.H#$Y#R
M!!.T_/,$)2MPP>.PVWHVLHYOS@D$E$<?\Q`05%#RQQNT_C$$#V>=M\9XD\X*
M`.27;_[YZ*=/_M?7]WO!!B6SW;("RBHP_[C7KB(Z[V0'P,$$HF/;U@C`@<?9
M+F\$2-LJXL8_@2D@`Q`(WO7HEC>]C2L#XPJ`Q72%"^A)+WH@F,`#NF<K#'C.
M=:*SW[D"J$!<4$!],(PA!G<G-`[`[UP/"*#*/&`]EI%CAPT46``VP(&`0:U[
M!'C`]11@L=+-(V!!/)?O*,`Y*"I`<*I3HNI(R`%:?7!R$^``!4BX-@J`;VU:
M1-;^.$B/"XCKC7",HQSE*+`*;/\@8/9K7\"4!A`@1A%=9[LCNC!0P5Y)L84`
MV=\?I96!#5"`AJNS6+^D""_!O#"&F"0?!Q[P@`Q(4HV%),#^V(:=!\SQE'+\
M)+I\UT.S29*4#O+C'Q_8RG,%8'=T&],-H\@`0GI270J`8@`0Z2%[91)]`0``
M[0+0/E<VDXVR2N,BE:<`&@:@DA@#X"(9H,%F,D!G&"O"!11)-B96,UW?#&<2
M[(7*;FKPEJHL(3C5J84+_!)UOGO`!>AYAC`J\Y;I$E<&7L?/@AKTH`A-J$(7
MBA&PH(6A='`H1!$AT8G6H:(6G0-&,YJ&C7;P`>6CP#Z)<(%+/B!F(@6!L"X0
M1@Y@4Z7_PL+F`5X1D08$9DX2>85![A"14!"A`S1]PCTT`)$%H$5=\Y1EL+[%
M@)(I#0#M8T#4P&(2%+4A#DF9!$3H$A&K=@D>)G&"(UH"A;7`:EUI8UJZ=)8N
M70GO7!PPP#@,Y:9=P*0G'0(!&\I#'];LY$[7<$(T\/&$,F0``,+:91>QA@%A
M^8R@W^I7,HEW-*CVRPB+<`0;8`6"BC[!%RV)$5CX1`3JI`A#@"4"L[JX6B'D
M*W^1G:>R%'BWBQV$IXY8A$@D^E=+/"-&;'AH9QE1A$_$HFKBNAYKEZJVK`WA
M7ZZ]['-M98Z@/B&W;AJ"1.M2D1@5Q`A@X>QP8Y2\='7Q81QD_Q9LH=M</D:6
MI@VHS2NP&YCA&H*[C%+%=XL`%O9DBBL/(\!A?=9%E6G0>;AJ5G2S-5T/?-94
M;M+M3PU4H"L=X1GB'6\1.N2SO;56<^BJ`!'8.[5G(8NX$-9L=3(5"R?X9SO,
ML<,3XO(*82#K6@5D[O[.5@3VGNYG0L`:`=J@"FR(%02[J,Q!9@JH-EA&`UBH
M<`*PT(<X.*$7:9E-'*"(K"Y.+68C;7`1QM6^"E@W(D>J2"SH.I'H4,01U*'(
M/=3:Y>8"<F^1+4)YSS6T.3FA&X"(28O8<@`!+,03M(A"8#0P(%X(0!3O"$-\
MZ\N!KP6``AL@WSX9B*Z1OM$(]N05`2TN34R#A@P#Y:,7-#F:!)^U,&*K9O41
9F+<^U\E:"V1$UM!NG863I:L"I?9"$```.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
